New magnetic-resonance-imaging-visible poly(epsilon-caprolactone)-based polyester for biomedical applications by S. Blanquer et al.
New magnetic-resonance-imaging-visible poly(epsilon-
caprolactone)-based polyester for biomedical applications
Submitted by Emmanuel Lemoine on Fri, 07/18/2014 - 13:52
Titre New magnetic-resonance-imaging-visible poly(epsilon-caprolactone)-based polyesterfor biomedical applications
Type de
publication Article de revue
Auteur
Blanquer, Sébastien [1], Guillaume, Olivier [2], Letouzey, Vincent [3], Lemaire,
Laurent [4], Franconi, Florence [5], Paniagua, Cédric [6], Coudane, Jean [7], Garric,
Xavier [8]
Editeur Elsevier











acid [9], biomaterials [10], complex [11], Delivery [12], dendrimers [13], dtpa [14],
enhancing coating material [15], gadolinium [16], Magnetic Resonance Imaging [17],
MRI [18], mri contrast agents [19], polycaprolactone [20], polymers [21], prosthesis
[22], Stability [23], visualization [24]
Résumé en
anglais
A great deal of effort has been made since the 1990s to enlarge the field of magnetic
resonance imaging. Better tissue contrast, more biocompatible contrast agents and
the absence of any radiation for the patient are some of the many advantages of
using magnetic resonance imaging (MRI) rather than X-ray technology. But
implantable medical devices cannot be visualized by conventional MRI and a tool
therefore needs to be developed to rectify this. The synthesis of a new MRI-visible
degradable polymer is described by grafting an MR contrast agent (DTPA-Gd) to a
non-water-soluble, biocompatible and degradable poly(epsilon-caprolactone) (PCL).
The substitution degree, calculated by H-1 nuclear magnetic resonance and
inductively coupled plasma-mass spectrometry, is close to 0.5% and proves to be
sufficient to provide a strong and clear T1 contrast enhancement. This new MRI-
visible polymer was coated onto a commercial mesh for tissue reinforcement using
an airbrush system and enabled in vitro MR visualization of the mesh for at least 1
year. A stability study of the DTPA-Gd-PCL chelate in phosphate-buffered saline
showed that a very low amount of gadolinium was released into the medium over 52
weeks, guaranteeing the safety of the device. This study shows that this new MRI-
visible polymer has great potential for the MR visualization of implantable medical
devices and therefore the post-operative management of patients. (C) 2011 Acta
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